A5071526393- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies
- Cardiomyopathy and Myosin Studies
- Cardiovascular Effects of Exercise
- Cardiac Imaging and Diagnostics
- Cardiovascular Syncope and Autonomic Disorders
- Cardiovascular Function and Risk Factors
- Botulinum Toxin and Related Neurological Disorders
- Robot Manipulation and Learning
- Pain Management and Treatment
- Cerebrovascular and Carotid Artery Diseases
- Connective tissue disorders research
- Robotic Path Planning Algorithms
- Lanthanide and Transition Metal Complexes
- Acute Ischemic Stroke Management
- Cancer-related gene regulation
- Ion channel regulation and function
- Coronary Artery Anomalies
- Aortic aneurysm repair treatments
- Venous Thromboembolism Diagnosis and Management
- Sports injuries and prevention
- Vitamin K Research Studies
Hospital of the University of Pennsylvania
2024-2025
University of Pennsylvania
2024
Université de Montréal
2023-2024
Montreal Heart Institute
2023-2024
Universitätsklinikum St. Pölten
2020-2021
Krankenhaus der Elisabethinen
2020
RHI Magnesita (Austria)
2017
An 84-year-old man presented to the hospital with recurrent palpitations.His symptoms had started about 2 months earlier, shortly after β-blocker discontinuation due bradycardia incidentally noted on ECG (Figure 1).It is notable that he was asymptomatic at time and never experienced lightheadedness or syncope despite taking β-blockers for more than a decade.His entire physical examination an echocardiogram were unremarkable.After discontinuation, no longer bradycardic but palpitations...
Introduction/ Background: Individuals with chronic kidney disease (CKD) are at an increased risk for developing atrial fibrillation (AF). Research Objective: By integrating genomics and proteomics, we sought to identify proteins biologic pathways causally linked the development of AF in CKD population. Methods / Approach: We measured 4638 unique plasma using SomaScan v.4.0 participants (ppts) no prior from 2 cohorts: Chronic Renal Insufficiency Cohort (CRIC, n=2654) Atherosclerosis Risk...
Abstract Aims Cerebral thromboembolic events are well-known complications of pulmonary vein isolation (PVI) and can manifest as stroke or silent cerebral embolic lesions. Over the last years, preferred oral anticoagulation in atrial fibrillation (AF) shifted from vitamin K antagonists (VKA) to non-vitamin K-dependent anticoagulants (NOAC). The aim this study was compare incidence lesions after AF ablation patients on VKA versus NOAC, identify corresponding clinical procedural risk factors....